Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001125345-25-000047
Filing Date
2025-04-11
Accepted
2025-04-11 16:00:50
Documents
17
Period of Report
2025-05-21

Document Format Files

Seq Description Document Type Size
1 DEF 14A mgnx-20250411.htm   iXBRL DEF 14A 983716
3 SIGNATURE mgnx-20250411_g1.jpg GRAPHIC 12731
4 PVP CHART mgnx-20250411_g2.jpg GRAPHIC 120485
5 PROXY CARD PAGE 1 mgnx-20250411_g3.jpg GRAPHIC 1345921
6 PROXY CARD PAGE 2 mgnx-20250411_g4.jpg GRAPHIC 551786
  Complete submission text file 0001125345-25-000047.txt   6160263

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mgnx-20250411.xsd EX-101.SCH 922
19 EXTRACTED XBRL INSTANCE DOCUMENT mgnx-20250411_htm.xml XML 117379
Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Filer) CIK: 0001125345 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36112 | Film No.: 25831494
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)